Skip to main content
Toggle navigation
Main navigation
Home
About
About Us
Our Partners
Our People
Projects
Adverse Events of Special Interest in NZ Primary Care
African COVID-19 Vaccine Safety Surveillance (ACVaSS)
Epidemiological assessment of adverse events following measles, mumps, and rubella (MMR) vaccination
Genomics of COVID-19 Vaccine-Induced Adverse Events
Global COVID Vaccine Safety (GCoVS)
NZ Gold Study
SAFE Project: NZ Background rates of AESIs for COVID-19 vaccination
Resources
Blogs
Data Dashboards
News
Newsletter
Publications
Useful Links
Videos and Webinars
Contact
Search
Search
Collaborating on vaccine safety and effectiveness studies using health data from around the world.
Home
News
GVDN Mobile Menu
Home
About
About Us
Our Partners
Our People
Projects
Adverse Events of Special Interest in NZ Primary Care
African COVID-19 Vaccine Safety Surveillance (ACVaSS)
Epidemiological assessment of adverse events following measles, mumps, and rubella (MMR) vaccination
Genomics of COVID-19 Vaccine-Induced Adverse Events
Global COVID Vaccine Safety (GCoVS)
NZ Gold Study
SAFE Project: NZ Background rates of AESIs for COVID-19 vaccination
Resources
Blogs
Data Dashboards
News
Newsletter
Publications
Useful Links
Videos and Webinars
Contact
News
14 December 2022
GVDN Data dashboards provide a reliable source of information for media
30 September 2022
GVDN welcomes Professor Jim Buttery as third Co-Director
12 August 2022
Responding to the need: GVDN includes smallpox vaccine in global vaccine safety surveillance
20 April 2022
GVDN™ partners in Finland and Denmark review post-mRNA COVID vaccination myocarditis and pericarditis in 23 million Nordic residents
13 April 2022
Pandemic propels global effort to study rare vaccine side effects
27 March 2022
Pregnancy outcomes following COVID-19 vaccination in Ontario, Norway, and Sweden
25 March 2022
Immunising against misinformation, we all have a role
26 January 2022
Hong Kong partners publish outcomes from carditis and COVID-19 vaccination association study
25 January 2022
NZ hosts vaccine safety project
